• Minoli Perera

    The Perera Lab

     

    Associate Professor

    Northwestern University

  • The Perera laboratory focuses on pharmacogenomics (using a patient's genome to predict drug response) in minority populations. Our goal is to make precision medicine available to all.

    Dr. Perera is an Associate Professor within the Department of Pharmacology and Center for Pharmacogenomics at the Feinberg School of Medicine with expertise in pharmacokinetics, clinical pharmacology and human genetics.

    Why we do what we do!

    Currently there is a lack of diversity in genomic studies in general (check out this Cell paper to see some great graphics) and pharmacogenomic studies in particular. This means that as we begin to use genomic data to guide therapy in the US, we may be unable to accurately predict drug response in under-served populations. We (and our amazing collaborators) hope to fast-track the discovery and translation of genetic variants that affect response to medication for African Americans. For me this research focus started as an interesting area that few others were working in...but now it is a calling to do something that can make medical care better for those that have gone unrecognized (or un-ACCOuNTed).

  • Media

    Northwestern's Breakthrough Podcast on our newest paper!

  • The Perera Lab Blog

    Thoughts, musings, and ruminations.

    February 1, 2018
    My cousin` and me soon after arriving in the US. There has been a lot of conversation around immigration after the State of the Union Address this week and all of this has really made me think of what "immigrant" means to me. To those that don't know me, I was not born in the the great US of A,...
    May 23, 2017
    I along with a few close friends (some that are STEMinists (my new favorite word), and some that work in STEM), joined the March of Science in Chicago (that's me being eaten by the skeletal T.Rex). It felt great and was a bit cathartic, but it was a stark reminder that there is so SO much more to...
    November 1, 2016
    While in the midst on switching institutions, growing my lab and figuring out how things work around here, I received the awesome news that the U54 Collaborative Consortium grant I had put in over a year ago was funded! Now to actually do the work promised. Staring down at the proposal, all I...
  • Collaborators/Consortiums

    We could all use a little help from our friends.

    Larisa Cavallari Perera Lab

    Larisa Cavallari

    University of Florida

    broken image

    Vanderbilt University

    Dr. Eric R Gamazon develops and applies genomic and computational methods to investigate the genetic architecture of complex traits, including disease risk and drug response. He is interested in what can be learned from DNA sequence and multi-omics data about disease mechanism, therapeutic intervention, molecular evolution, and biological function.

    Travis O'Brien Perera Lab

    George Washington University

    Director of the Pharmacogenomics Program and Associate Research Professor of Pharmacology and Physiology

    broken image

    Pharmacogenomics Research Network

    The PGRN catalyzed pharmacogenomics discoveries both nationally and internationally through the conduct of collaborative research focused on the discovery and translation of the genetic determinants of drug response, in order to enable safer and more effective drug therapies.

    broken image

    University of Puerto Rico

    Professor at the School of Pharmacy, University of Puerto Rico

  • Contact Information

  • CONTACT US!